Background Variations exist in the surgical techniques used for caesarean section and many have not been rigorously assessed in randomised controlled trials. We aimed to assess whether any surgical techniques were associated with improved outcomes for women and babies.
Introduction
Caesarean section is one of the most commonly undertaken operations worldwide and accounts for up to 60% of deliveries in some countries.
1-3 Caesarean section carries a risk of short-term postoperative morbidity, for example, fever, pain, post-partum haemorrhage, damage to the bladder or ureters, and thromboembolic disease. Long-term clinical and obstetric problems include chronic pain, infertility, bowel obstruction, abnormal placen tation and its consequences, and uterine rupture. [4] [5] [6] Caesarean section is not done in a standardised way, and there are variations in the surgical techniques used. 7, 8 Many of the surgical techniques have not been rigorously assessed in randomised controlled trials and so whether any of them are associated with better outcomes for women and babies is not known. 7 Because large numbers of women undergo caesarean section, even small diff erences in postoperative morbidity between techniques could mean improved health for a large number of women and substantial savings for health services. Rigorous random ised controlled trials are needed to establish the eff ective ness of diff erent surgical techniques. We therefore undertook the present trial to assess whether fi ve specifi c approaches to the surgical techniques were associated with improved outcomes for women and babies.
Methods

Study design and participants
After widespread interest from many countries to participate in the UK trial of caesarean section surgical techniques (CAESAR), 9 WHO funded a workshop in Oxford, UK, to develop a proposal for a new trial to be undertaken in these countries. At this workshop, investigators reviewed all the available evidence for each element of the caesarean section operation and produced, through a formal consensus process, a ranked list of candidate intervention pairs to include in the trial. Eligibility for inclusion as a trial intervention was based on a range of criteria including the clinical importance of resolving the uncertainty for short-term and long-term outcomes, the quality and quantity of available evidence, and the feasibility of undertaking the interventions in the participating countries.
Based on the fi ndings from the workshop, we undertook a multicentre, unmasked, randomised controlled trial at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan to assess two surgical techniques (intervention pairs) for fi ve elements of the caesarean section operation. The fi ve intervention pairs were as follows: (1) blunt versus sharp abdominal entry; (2) exteriorisation of the uterus for repair versus intraabdominal repair; (3) single-layer versus double-layer closure of the uterus; (4) closure versus non-closure of the peritoneum (pelvic and parietal); and (5) chromic catgut versus polyglactin-910 for uterine repair. The methods have been summarised previously. 10 Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies. Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.
The National Perinatal Epidemiology Unit Clinical Trials Unit (Oxford, UK) and each participating site secured approval from their research ethics committee or equivalent body. The trial was overseen by an independent trial steering commit tee. An independent data monitoring com mit tee monitored eff ectiveness and safety annually. The data monitoring committee used the Haybittle-Peto 11, 12 approach for interim analyses using three standard errors as the cutoff for consideration of early cessation, preserving the type-one error rate across the trial.
Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent. Information leafl ets were made available, in appropriate languages, which explained the trial objectives, the process of trial entry, and follow-up. The trial was discussed with all eligible women and their partners and relatives as appropriate. If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting (eg, a thumb print).
Randomisation and masking
Although there were fi ve intervention pairs, each site was assigned only three to maximise compliance (appendix), thereby making this a 2×2×2×2×2 fractional, factorial trial (more correctly termed a non-regular fractional, factorial trial). 13 Women were randomly allocated to one intervention from each of the three assigned pairs. Randomisation was done using a bespoke secure web-based system, with a 24-h automated telephone back-up.
The system allocated a number corresponding to a unique allocation envelope held at participating sites. The allocation numbers were generated by computer implementation of a pseudo-random generating algorithm. Each envelope contained an allocation sheet detailing the three allocated interventions for a woman, as a reminder to the surgeon. In instances where there was no internet or telephone connectivity, the recruiting clinician selected the lowest sequentially numbered allocation envelope. All randomisation data were held centrally at the international coordinating centre (National Perinatal Epidemiology Unit Clinical Trials Unit).
We used minimisation to ensure balance within sites, within and between intervention pairs, and with respect to in-labour and not in-labour caesarean section and fi rst or second caesarean section. For sites where chromic catgut versus polyglactin-910 was one of the assigned intervention pairs, supplies of both suture materials were provided by the international coordinating centre and were contained in a specifi c trial box stored in the operating theatre.
All investigators, surgeons, and participants were unmasked to treatment allocation.
Procedures
Each regional coordinator (one per country, except India, which was split into two regions) started and documented a train ing programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating. To facilitate this, the international coordinating centre gave a DVD of the interventions tested to all study sites.
The procedures for blunt versus sharp abdominal entry were as follows. For sharp entry, the abdomen was entered using a scalpel to divide the abdominal skin. Each subsequent layer of the abdomen was then separately identifi ed and divided using either a scalpel or scissors. In blunt entry, the abdomen was entered using a scalpel to divide the abdominal skin. The scalpel was then used to divide the fat and rectus sheath in the midline and the rectus sheath incision extended manually. The parietal peritoneum was then entered digitally and the defect enlarged manually.
For exteriorisation of the uterus for repair versus intraabdominal repair, once the placenta had been delivered, either the uterus was drawn from the pelvis to rest on the anterior abdominal wall so that the uterine incision could clearly be visualised or the uterus was repaired while in the pelvis.
For the comparison of single-layer versus double-layer closure of the uterus, the uterine incision was closed with either one or two layers of sutures. Each layer could be closed using any accepted technique. Haemostasis of the incision could be done with additional sutures as judged necessary by the surgeon regardless of the method of closure undertaken.
For closure versus non-closure, the pelvic and parietal peritoneum was either closed or not closed. For either See Online for appendix technique, haemostasis was achieved as usual, including, where necessary, the use of haemostatic sutures.
Finally, for chromic catgut versus polyglactin-910 for uterine repair, the uterus was repaired using either number 1 chromic catgut (Medsurge, Philadelphia, PA, USA) or number 1 polyglactin-910 (Ethicon, Livingston, NJ, UK). This could be a continuous, continuous locking, or an inter rupted layer of sutures. For sites where chromic catgut versus polyglactin-910 was one of the assigned intervention pairs, surgeons were asked to restrict their use of the allocated suture material to repair of the uterine incision and to use their usual suture material for all other layers.
All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon. In particular, there were no restrictions on the type of suture material that could be used, and standard measures to achieve haemostasis were employed regardless of the allocated intervention.
The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit. Maternal infectious morbidity was defi ned as one or more of the following: antibiotic use for maternal febrile morbidity during postnatal hospital stay or for endometritis, wound infection, or peritonitis up to the 6-week follow-up visit. Blood transfusion as part of the composite primary outcome was changed on June 14, 2010, from any blood transfusion to transfusion of more than 1 unit of blood when the data monitoring committee and international coordinating centre became aware that one site was transfusing 1 unit of blood routinely.
Secondary outcomes consisted of the individual components of the primary outcome as well as pain, †Included in the primary analysis. ‡Ascertained after randomisation. §Randomised twice because the woman had a previous caesarean section in the CORONIS trial. ¶Two were going to have a hysterotomy, one a colpotomy, one was a uterine rupture known before trial entry, and one had a rudimentary horn pregnancy. interventions used for severe primary post-partum haemorrhage, stillbirth after trial entry, other severe maternal morbidity, Apgar score less than 3 at 5 min, laceration of baby at time of caesarean section, and death of the baby by 6 weeks of age. Secondary health service utilisation outcomes consisted of the duration of the operation, duration of hospital stay, admission to intensive care and duration of stay, and readmission to hospital within 6 weeks and duration of stay.
Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery. Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit. Serious adverse events were assessed by the chief investigator and data monitoring committee as soon as they were reported to the international coordinating centre.
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Maternal characteristics at trial entry
Mother's age (years) Data are number (%) or mean (SD), unless otherwise stated. Missing data are <1% unless otherwise presented. Some percentages do not total 100 because of rounding. Excludes women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). Additional baseline characteristics are detailed in the appendix. N/A=not applicable. PG-910=polyglactin-910. *Intervention pairs not assigned in these regions. †Some sites within these regions switched intervention pairs. ‡Women with no previous births. A previous birth is defi ned as a live or stillbirth of estimated gestational age >24 weeks (or >28 weeks depending on country-specifi c defi nitions), regardless of previous mode of delivery or multiple pregnancy (multiple pregnancy counts as one birth). 
Statistical analysis
A sample size of 15 000 women was needed, with at least 9000 women in each intervention pair, to have at least 80% power to detect a 15% relative risk reduction in the primary outcome from a baseline incidence of 15% (estimated from a pilot study of 855 consecutive women who were to undergo a caesarean section [Brocklehurst P, unpublished]), assuming 15% loss to follow-up. A detailed statistical analysis plan was developed and approved by the trial steering committee (appendix). For the analysis of maternal outcomes, women were analysed in the groups into which they were allocated; for example, comparing women allocated to blunt abdominal entry with those allocated to sharp abdominal entry, regardless of what interventions they actually received. For the analysis of neonatal outcomes, neonates were analysed according to the groups allocated to the women. Neonatal outcomes were only analysed in the intervention pair blunt versus sharp abdominal entry because these were the only interventions that could have an eff ect on neonatal outcomes. In the analysis of neonatal outcomes, neonates from multiple births were treated as independent, but the eff ect of adjusting for potential clustering was also assessed. 14 The focus of the primary analysis was the main eff ects of the fi ve intervention pairs analysed separately. Pairwise interactions were planned if the analyses showed any statistically signifi cant main eff ects for the primary outcome only. Subgroup analyses according to caesarean
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Repair of uterus Closure of uterus Closure of peritoneum Uterine repair sutures Total (n=15 729) 
Antibiotics for peritonitis Missing data are <1% unless otherwise presented. Excludes women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). CI values are 95% for primary outcome and 99% for all others. PG-910=polyglactin-910. RR=risk ratio. *A woman may have more than one component but is included only once in the primary outcome. Primary outcome defi ned as death or maternal infectious morbidity or further operative procedures or blood transfusion (>1 unit of whole blood and packed cells only). †Maternal infectious morbidity defi ned as one or more of the following: antibiotic use for maternal febrile morbidity during post-partum stay (fever on at least two occasions); antibiotic use for endometritis, wound infection, or peritonitis up to 6 weeks post partum. ‡Includes any operative procedures on caesarean wound, curettage, laparotomy, artery ligation, brace suture, and hysterectomy. §>1 unit of whole blood and packed cells only. Missing data are <1% unless otherwise presented. Excludes women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). ICU=intensive care unit. MD=median diff erence. PG-910=polyglactin-910. RR=risk ratio. *Includes any procedures on the wound because of infection, dehiscence, or haematoma. †Includes additional uterotonics, balloon tamponade, brace suture, artery ligation, and hysterectomy. ‡Includes at least one of the following: antibiotics for peritonitis (n=5), antibiotics for sepsis (n=8), antibiotics for infection (n=3), post-partum haemorrhage (n=24), deep-vein thrombosis (n=7), pulmonary embolism (n=0), or septic shock (n=2). §Women in some centres were kept in for rest or to wait for the baby to be discharged. ¶In some sites, women were admitted to the ICU routinely; these women have been excluded from this analysis. ||If admission date and discharge date were the same, the length of stay was regarded as 1 day. Six women had two re-admissions; their lengths of stay have been summed. the primary outcome and less than 0·01 for all secondary outcomes and subgroup analyses. An adjusted analysis was prespecifi ed for the primary outcome to investigate the eff ect of minimisation factors: in-labour versus not in-labour caesarean section and number of previous caesarean sections. Several sensitivity analyses of the primary outcome were also prespecifi ed in the analysis plan. All analyses were undertaken using Stata/SE (version 11.2).
RR (99% CI)
The CORONIS trial is registered with Current Controlled Trials, ISRCTN31089967.
Role of the funding source
The trial was funded by the UK Medical Research Council. WHO contributed to the cost of the initial protocol development meeting and site set-up costs in the fi rst year. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
Between May 20, 2007 , and Dec 31, 2010, 15 935 women were recruited at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan (appendix). The appendix describes the character istics of the participating countries and sites.
After the second meeting of the data monitoring committee on July 22, 2009, when data from 7972 women were reviewed, the data monitoring committee informed the trial steering committee that, instead of an expected primary outcome incidence of around 15%, the incidence was 4·7%. The investigators assessed this discrepancy, masked to treatment allo cation, and found that the overall incidence of the primary outcome varied substantially between sites and consequently an extensive validation exercise was undertaken between Aug 13, 2009, and March 3, 2011 (appendix). Validation was done by independent observers and included reviewing source records and interviewing participating women. This exercise resulted in an overall primary outcome incidence of 9·3%. After considering many scenarios, the trial steering committee recommended continuation of recruitment until the end of 2010 (4 months later than planned), when about 16 000 women would have been enrolled. This would still give 80% power to detect a relative risk reduction of 0·825 if the overall primary outcome incidence was at least 9·0%. To ensure at least 9000 women were included in each intervention pair, close monitoring of recruitment was done weekly by the international coordinating centre. This led to three sites switching intervention pairs in 2010 (appendix).
In accordance with the prespecifi ed analysis plan, 206 (1·3%) of the 15 935 women were excluded from the analysis, of whom 143 (0·9%) had a vaginal delivery (fi gure 1). These women were evenly distributed among the intervention pairs and were excluded from the analysis because they were not at risk of wound-related problems. Trial entry and discharge data were available for 15 913 (99·9%) of 15 935 women and 6-week data for 15 611 (98·0%) women (fi gure 1). Compliance with all the allocated interventions was high, 87% overall (fi gure 1). The diff erence in compliance between single and double layer closure of the uterus (83% vs 98%, respectively) was mostly explained by clinical decisions during surgery.
Baseline characteristics were similar within and across inter vention pairs (table 1; appendix). The mean age was 27·0 years (SD 5·4), almost half were nulliparous, about a third were undergoing a second caesarean section, just over half underwent caesarean section before the start of labour, and 15% were less than 37 weeks gestation. 99% of women received prophylactic antibiotics and prophylactic uterotonics and 7% received prophylactic heparin (appendix).
The incidence of the primary outcome was 9·3% overall and varied from 7·3% to 10·7% by intervention pair (table 2) . There were no statistically signifi cant diff erences within any of the intervention pairs for the primary outcome (table 2). As prespecifi ed in the analysis plan, no tests for interaction were done because there was no evidence of main eff ects for the primary outcome. There was only one statistically signifi cant diff erence in one component of the primary outcome, which was for the intervention pair chromic catgut versus polyglactin-910 for uterine repair and the outcome of blood transfusion greater than 1 unit (risk ratio 0·53, 99% CI 0·30-0·93; table 2). On further assessment, this result was robust when adjusted for in-labour versus not in-labour caesarean section and suture material used as standard in each site (data not shown).
There was no evidence of a diff erence within intervention pairs for any of the other secondary outcomes (table 3) . For the intervention of blunt versus sharp abdominal entry, where the potential diff erence in the time taken to enter the abdominal cavity might lead to worse neonatal outcomes, there was no evidence of a diff erence in the risk of stillbirth or low Apgar score (table 4). These fi ndings did not change after allowing for clustering for multiple births (table 4) .
There was limited consistent and corroborated evidence of a diff erential treatment eff ect between the subgroups in the eff ect of the interventions on the primary outcome (fi gures 2-6). We cannot explain the diff erences for Argentina in the comparison of blunt versus sharp abdominal entry and for Chile in the comparison of chromic catgut versus polyglactin-910 and assume that they are spurious associations because of the large number of comparisons made. Not all the prespecifi ed subgroup analyses were undertaken because the size of some of the subgroups was too small. HIV infection was present in only 2% of women and intrapartum fever in only 2% (table 1). The adjusted analyses (appendix) and the sensitivity analyses (table 5) resulted in no eff ect on the fi ndings for the primary outcome.
144 serious adverse events were reported, of which 26 were possibly related to the intervention (appendix). Most of the reported serious adverse events were known complications of surgery or complications of the reasons for the caesarean section; for example, obstructed labour is a risk factor for post-partum haemorrhage. The intraabdominal bleeding and uterine atony that occurred might have been because of the surgical techniques being used. For example, uterine atony might be caused or exacerbated by the method of closure of the uterine incision (exteriorisation or intra-abdominal repair), single-layer or double-layer closure of the uterus, or the use of chromic catgut or polyglactin-910 sutures. The appendix shows the distribution of all the serious adverse events and those thought to be possibly related to the allocated intervention, by randomised intervention pairs. There were no statistically signifi cant diff erences in the incidence of serious adverse events. The serious adverse events that were possibly related to the allocated intervention were 18 haemorrhage (uterine atony or intraabdominal bleeding) and six serious infections. The serious adverse events included 16 deaths, of which one was possibly related to the intervention. This was a death due to septicaemia secondary to peritonitis after presumed intestinal perfora tion. Four deaths were due to hypertensive disease; two to aspiration pneumonitis; two to obstetric haemor rhage; two to thromboembolic disease; one each to renal failure, stroke, brain tumour, and H1N1 variant infl uenza; and one unknown cause in a woman with hepatitis C.
Discussion
CORONIS was a large randomised trial of caesarean section surgical techniques and provides important evidence to guide clinical practice (panel). There were no statistically signifi cant diff erences within any of the intervention pairs for the primary outcome. However, there was a statistically signifi cant diff erence in one component of the primary outcome: chromic catgut versus polyglactin-910 for uterine repair.
This study has limitations. We were unable, for practical reasons, to assess all aspects of the caesarean section operation that could aff ect maternal morbidity. Our choice was based on a consensus meeting of investigators who prioritised aspects of the operation as being those for which there was little evidence to support either approach, or for which there was the potential for important short-term or long-term implications, such as single-layer versus double-layer uterine closure and uterine rupture during a subsequent pregnancy. Compliance was generally very good; however, for mostly clinical reasons, surgeons could not always comply with the allocated intervention. This might weaken the diff erences between randomised groups, but represents the pragmatic nature of the trial, thus the fi ndings are generalisable. For sites where chromic catgut versus polyglactin-910 for uterine repair was one of the assigned intervention pairs, surgeons did not always follow the trial protocol and used the suture material allocated for closing the uterine incision to close other layers (appendix). However, adjusting for this non-compliance made no diff erence to the risk ratio for the primary outcome (appendix). The incidence of the primary outcome was lower than anticipated, as was maternal mortality. This fi nding is a result of the nature of recruitment of participants to randomised controlled trials who are potentially healthier than the represented patient population. The pilot study (Brocklehurst P, unpublished) assessed outcomes for consecutive caesarean sections taking place in several of the CORONIS participating sites. By introducing a process of enrolment into a trial, women with the greatest risk of an adverse outcome are less likely to be recruited; this includes women who were to undergo a caesarean section in labour but were judged to be unable to provide informed consent. This factor might also explain the low maternal mortality in this sample of women. Because of the lower than expected frequency of the primary outcome, we undertook an extensive validation exercise. Validation revealed that follow-up personnel were sometimes missing important outcomes, such as wound infections. Review of source documents and re-interviewing women (by independent staff ) identifi ed several unreported outcomes; extensive additional training was initiated to ensure accurate data capture of these outcomes at the postnatal interview for the remainder of the trial.
Despite these potential limitations and the lower than anticipated incidence of the primary outcome, this trial had suffi cient power to identify modest diff erences in short-term outcomes. The only intervention-outcome combination for which there was statistical evidence of an eff ect was blood transfusion of greater than 1 unit for the chromic catgut versus polyglactin-910 compari son. When we explored the reasons for the blood transfusion, there was an increase in the number of women having a blood transfusion for post-partum haemorrhage in the polyglactin-910 arm compared with the chromic catgut arm. The number of cases was small (36 vs 20), so the fi ndings could have arisen by chance. However, there is no suggestion, as was widely anticipated, that polyglactin-910 was superior to chromic catgut.
CORONIS provides evidence, on the basis of shortterm outcomes, that clinicians can remain free to use whichever surgical technique they prefer. Although undertaken in low-income and middle-income countries, these fi ndings are probably generalisable to other settings. The complications of caesarean section are the same in all settings, albeit with diff erent frequencies. The primary outcome of death or maternal infectious morbidity or further operative procedures or blood transfusion (>1 unit of whole blood and packed cells only) was analysed by time to follow-up after delivery. Maternal infectious morbidity defi ned as one or more of the following: antibiotic use for maternal febrile morbidity during post-partum stay (fever on at least two occasions); antibiotic use for endometritis, wound infection, or peritonitis up to 6 weeks post partum. Includes any operative procedures on caesarean wound, curettage, laparotomy, artery ligation, brace suture, and hysterectomy. Excludes women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). A woman can have more than one component but is included only once in the primary outcome. p values were 0·91 for abdominal entry, 0·08 for repair of uterus, 0·28 for closure of uterus, 0·09 for closure of peritoneum, and 0·22 for uterine repair sutures. RR=risk ratio. PG-910=polyglactin-910. *Number presented in fi gure 1 does not exclude women randomised in error, women who withdrew consent, data not received, and vaginal deliveries. Primary outcome data are not treated as missing if a primary outcome event is recorded on the post-partum form (ie, before the 6 weeks after delivery form). This review included 11 randomised controlled trials (with a total of 1740 women) that compared diff erent approaches to abdominal entry, which are comparable to the comparison blunt versus sharp abdominal entry in the CORONIS trial (described as Joel-Cohen based versus Pfannenstiel). The fi ndings from this review suggested that the blunt approach to abdominal entry led to less blood loss, a shorter duration of surgery (including a shorter duration from skin incision to delivery of the baby), and less postoperative fever and pain. More serious complications, including blood transfusion of the mother, were too few to analyse. The main challenge of interpreting these eponymous techniques is that, if done as intended, they include prescribed techniques for uterine incision closure and abdominal wound closure, 15 making interpretation of outcomes in relation solely to the method of abdominal entry diffi cult.
Exteriorisation of the uterus for repair versus intra-abdominal repair was the topic of a systematic review published in 2009, which included 11 trials with 3183 women in total . 16 The investigators found no evidence that one approach was superior to the other for several outcomes such as intraoperative or postoperative complications including endometritis, pain, and nausea and vomiting. There were no diff erences in the duration of the operation or in the duration of hospital stay. Since this study was published, a trial of 4925 women has been published. 17 This trial found an excess of uterine atony in the exteriorisation group (9·1% vs 3·8% in the intra-abdominal repair group), although there was no statistically significant difference in the incidence of blood transfusion. The intra-abdominal repair group had a shorter operating time and less postoperative pain and a lower incidence of wound infection (4·6% vs 11·5% in the exteriorisation group). This fi nding is in contrast to the CORONIS trial, which found no diff erences in these outcomes in 9795 women.
A Cochrane review of closure versus non-closure of the peritoneum (visceral or parietal or both) was last updated in 2008. 18 It incorporated 14 trials including 2908 women and found that non-closure reduced operating time, postoperative fever, use of pain relief, and hospital stay. Since this review was published, a further fi ve trials have been published. 9, [19] [20] [21] [22] Four of these trials are moderate in size (between 80 and 340 women per trial), [19] [20] [21] [22] whereas the CAESAR trial included 2995 women in this comparison. 9 Some of the smaller trials found similar fi ndings to the Cochrane review, with shorter operating times and less postoperative febrile morbidity in the non-closure group. However, the CAESAR trial found no diff erences in any outcomes of postoperative morbidity but did suggest that non-closure of the pelvic peritoneum shortened the duration of the operation by a mean of 2·3 min. In CORONIS, by contrast, we found no diff erence in duration of surgery.
A Cochrane systematic review of surgical techniques involving the uterus at the time of caesarean section included trials of single-layer versus double-layer closure of the uterine incision (ten trials with 2531 women in total). 23 Two further trials that compared single-layer and double-layer uterine closure published since the Cochrane review was last updated have been identifi ed, involving 208 women in one 24 and 2979 women in the other. 9 None of the existing studies suggest major diff erences in short-term outcomes between single-layer and double-layer uterine closure. There was a suggestion that single-layer closure might result in a decreased estimated blood loss at the time of caesarean section and shorter duration of the operative procedure, but the addition of the data from the large CAESAR trial suggests no diff erences in any of these outcomes. CORONIS, when added to the existing evidence, confi rms this absence of short-term diff erences in maternal morbidity.
There are no published or ongoing trials comparing diff erent suture materials for this element of the caesarean section operation.
Interpretation
The published trials of caesarean section surgical techniques are mostly small and inconclusive, and pooled estimates show, for some of the outcomes, substantial heterogeneity. With respect to the fi ve pairs of interventions included in CORONIS, all the available evidence suggests that blunt abdominal entry is unlikely to off er any short-term benefi ts for postoperative morbidity; non-closure of the peritoneum might decrease the duration of the operation by a small amount, but this does not translate into improvements in morbidity outcomes; single-layer closure of the uterine incision does not improve short-term morbidity outcomes; and the use of chromic catgut might have moderate advantages over the use of polyglactin-910. With respect to whether intra-abdominal repair of the uterine incision improves outcome, the available evidence is still uncertain. We found no evidence of improved outcomes for women in this comparison pair, in contrast to the fi ndings by Doganay and colleagues. 17 The fi ndings of CORONIS, when combined with the existing evidence, suggest that clinicians are free to carry on with their existing practices, at least with respect to their eff ect on short-term postoperative morbidity. However, particularly for interventions that involve closure of the uterine incision (single-layer versus double-layer closure or use of diff erent suture materials) as well as closure or non-closure of the peritoneum, longer-term outcomes are needed to enable clinicians to make fully informed decisions about what surgical approaches to take. tested intervention pairs in these settings is therefore likely to also apply to caesarean sections undertaken in high-income countries.
The potential eff ects of these surgical techniques on longer-term outcomes, such as the functional integrity of the uterine scar during subsequent pregnancies, is of increasing importance for guiding clinical practice. Longterm outcomes, even if uncommon, are likely to have a substantial eff ect on morbidity and can occasion ally result in life-threatening events or even death. There have been few follow-up studies of existing trials of caesarean section techniques and these studies are small (a total of just over 350 women). [25] [26] [27] For important outcomes such as uterine rupture (incidence 0·4-0·6%) and dehiscence (1·1%), [28] [29] [30] detection of diff er ences between alternative surgical techniques with adequate power is challenging. This absence of long-term follow-up data and the absence of short-term eff ects of these techniques raise important issues about present clinical guidance.
The short-term outcomes of the CORONIS trial might suggest that any of the fi ve pairs of surgical techniques is acceptable. However, until we have information from the ongoing CORONIS follow-up study, which is assessing women's health at least 3 years after the CORONIS caesarean section, we cannot assume that the absence of evidence of shortterm eff ects will translate into an absence of evidence of long-term eff ects.
